Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Hepatic Encephalopathy

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...

Cirrhosis II: Pathophysiology

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Determination of telomere length and telomerase activity in cattle infected with bovine leukaemia virus (BLV).

Polish journal of veterinary sciences·2019

Same author

Determination of cytokine profiles in populations of dendritic cells from cattle infected with bovine leukaemia virus.

Polish journal of veterinary sciences·2019

Same author

Effects of age, HIV, and HIV-associated clinical factors on neuropsychological functioning and brain regional volume in HIV+ patients on effective treatment.

Journal of neurovirology·2018

Same author

Pharmacological and dietary factors in prevention of colorectal cancer.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2018

Same author

Interlaboratory Comparison of Six Real-Time PCR Assays for Detection of Bovine Leukemia Virus Proviral DNA.

Journal of clinical microbiology·2018

Same author

Serum neutrophil gelatinase-associated lipocalin (NGAL) correlates with clinical and endoscopic activity in ulcerative colitis but fails to predict activity in Crohn's disease.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2018

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo

Published on: August 4, 2018

Coagulopathy in liver diseases.

A Pluta¹, K Gutkowski, M Hartleb

¹Basildon and Thurrock University Hospital, Basildon, Essex, United Kingdom.

Advances in Medical Sciences

|June 2, 2010

Summary

Liver cirrhosis causes hematological complications and coagulation issues. Despite these issues, patients often don't bleed spontaneously due to complex hemostatic abnormalities in advanced liver dysfunction.

Area of Science:

Hepatology
Hematology
Coagulation Science

Background:

Liver cirrhosis is linked to hematological problems and coagulation disturbances.
Coagulopathy is a significant complication in chronic liver failure and acute liver failure.
Hemostatic abnormalities are common in advanced liver dysfunction.

Purpose of the Study:

To review the complex coagulopathies in patients with advanced liver dysfunction.
To discuss the hemostatic abnormalities associated with liver cirrhosis.
To explore the relationship between coagulopathy, infection, and bleeding risk.

Main Methods:

Literature review of studies on liver cirrhosis and coagulation.
Analysis of hematological complications in liver disease.

More Related Videos

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

Published on: June 27, 2025

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Published on: August 4, 2023

Related Experiment Videos

Last Updated: Jun 12, 2026

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo

Published on: August 4, 2018

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

Published on: June 27, 2025

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Published on: August 4, 2023

Discussion of hemostatic abnormalities including thrombocytopenia, disseminated intravascular coagulation, fibrinolysis, hypofibrinogenemia, and dysfibrinogenemia.

Main Results:

Decreased production of coagulation factors by the liver is a primary cause of altered hemostasis.
An unstable balance of blood coagulation proteins, coupled with infection, exacerbates coagulopathy and bleeding risk.
Patients with severe liver disease exhibit multiple hemostatic abnormalities.

Conclusions:

Advanced liver dysfunction presents a complex picture of multiple coagulopathies.
Understanding these coagulopathies is crucial for managing bleeding risk in liver cirrhosis patients.
Further research is needed to fully elucidate the mechanisms and management of these hemostatic derangements.